Henry Schein (NASDAQ:HSIC) Announces Quarterly Earnings Results

Key Points

• Henry Schein reported earnings of $1.10 per share for the quarter, which missed estimates by $0.09, but revenue reached $3.24 billion, slightly above expectations.
• The company's stock fell 8.1% to $64.35, amid trading volume significantly higher than its average.
• Several analysts have adjusted their price targets for Henry Schein, with a consensus rating of "Hold" and an average target price of $78.08.

Henry Schein (NASDAQ:HSIC - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09), RTT News reports. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The business had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same quarter last year, the business posted $1.23 EPS. The company's quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS.

Henry Schein Stock Down 8.1%

Henry Schein stock traded down $5.67 during mid-day trading on Tuesday, hitting $64.35. The company had a trading volume of 2,962,837 shares, compared to its average volume of 1,736,743. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. The stock's 50 day moving average price is $71.58 and its two-hundred day moving average price is $71.30. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a market capitalization of $7.83 billion, a PE ratio of 20.11, a price-to-earnings-growth ratio of 2.20 and a beta of 0.81.

Institutional Investors Weigh In On Henry Schein

Hedge funds have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC bought a new stake in Henry Schein in the first quarter worth $676,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Henry Schein by 1.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company's stock valued at $1,155,000 after purchasing an additional 229 shares in the last quarter. Finally, AQR Capital Management LLC lifted its holdings in shares of Henry Schein by 47.3% during the first quarter. AQR Capital Management LLC now owns 30,402 shares of the company's stock valued at $2,071,000 after purchasing an additional 9,756 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Stifel Nicolaus restated a "hold" rating and set a $75.00 price target (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Piper Sandler dropped their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Barrington Research dropped their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Finally, Leerink Partners set a $75.00 price target on Henry Schein in a research report on Monday, July 14th. Nine investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $78.08.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.